SEC Form 4 · accession 0001222644-26-000004
Alamar Biosciences, Inc. · ALMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert P Ragusa
Director
Period of report
Sep 1, 2026
Accepted (ET)
Sep 3, 2026 · 4:27 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002104204
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2026 | A | 5,686 | $0.00 | A | 5,686 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $29.36 | Sep 1, 2026 | A | 25,599 | A | — | Aug 31, 2036 | Common Stock | 25,599 | 25,599 | D |
Explanation of responses
- F1Represents a restricted stock unit ("RSU") award. The RSUs vest in equal annual installments over 3 years measured from September 1, 2026, subject to the reporting person's continuous service as of each such vesting date.
- F2One-third of the shares subject to the option will vest on September 1, 2027 and the remainder of the shares subject to the grant will vest in equal monthly installments thereafter through September 1, 2029, subject to the reporting person's continuous service as of each such vesting date.